Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis

INTRODUCTION: Immune checkpoint inhibitors (ICI) such as anti-PD-L1 and anti-PD-1 agents have been proven to be effective in various cancers. However, the rate of non-responders is still high in all cancer entities. Therefore, the identification of biomarkers that could help to optimize therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Széles, Ádám, Fazekas, Tamás, Váncsa, Szilard, Váradi, Melinda, Kovács, Petra Terézia, Krafft, Ulrich, Grünwald, Viktor, Hadaschik, Boris, Csizmarik, Anita, Hegyi, Péter, Váradi, Alex, Nyirády, Péter, Szarvas, Tibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110702/
https://www.ncbi.nlm.nih.gov/pubmed/36385210
http://dx.doi.org/10.1007/s00262-022-03328-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110702/
https://www.ncbi.nlm.nih.gov/pubmed/36385210
http://dx.doi.org/10.1007/s00262-022-03328-9

Ejemplares similares